Data Foundry

Medical device recalls 2020

Lactate Dehydrognease P-L — Class II medical device recall Z-2963-2020

Terminated recall by Randox Laboratories Ltd., reported 2020-09-23, distributed nationwide. An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover av

Recall numberZ-2963-2020
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmRandox Laboratories Ltd., Crumlin (North), N/A, Ireland
Recall initiated2020-08-11
Classified2020-09-11
Reported by FDA2020-09-23
Terminated2020-10-15
DistributedNationwide (US)
Quantity4
Reason classespotency
UPC / GTIN / UDI-DI05055273204117
Lot numbers511979
Model numbersLD3818

Product

Lactate Dehydrognease P-L, (UV), Catalog Number LD3818 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in serum and plasma. This product is suitable for use on the RX series instruments which includes the RX daytona and RX imola.

Reason for recall

An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2963-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.